Insulin secreting and α-glucosidase inhibitory activity of Coscinium fenestratum and postprandial hyperglycemia in normal and diabetic rats

Journal of Medicinal Plants Research

Volumn 3, Issue 9, 2009, Pages 646-651

  Yibchok anun, Sirintorn ^a   Jittaprasatsin, Wanlaya ^a   Somtir, Damrong ^b   Bunlunara, Wijit ^a   Adisakwattana, Sirichai ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Faculty of Science   (Thailand)

Author keywords

glucosidase; Coscinium fenestratum; Insulin secretion; Perfused rat pancreas; Streptozotocin

Indexed keywords

ACARBOSE; ALCOHOL; ALPHA GLUCOSIDASE; ANTIDIABETIC AGENT; BERBERINE; COSCINIUM FENESTRATUM EXTRACT; GLIBENCLAMIDE; GLUCOSE; HYPERGLYCEMIC AGENT; SUCRASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROL GROUP; CONTROLLED STUDY; COSCINIUM FENESTRATUM; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG INHIBITION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IC 50; INSULIN RELEASE; LOADING TEST; MALE; MEDICINAL PLANT; NONHUMAN; PANCREAS; PANCREAS PERFUSION; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; STREPTOZOCIN DIABETES;

COSCINIUM FENESTRATUM; RATTUS;

EID: 73449085126     PISSN: 19960875     EISSN: 19960875     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Adisakwattana S, Charoenlertkul P, Yibchok-Anun S (2009). alpha-Glucosidase inhibitory activity of cyanidin-3-galactoside and synergistic effect with acarbose J. Enzyme Inhib. Med. Chem. 24:65-9.
2. Altan VM (2003). The pharmacology of diabetic complications. Curr. Med. Chem. 10: 1317-1327.
3. Baron AD (1998). Postprandial hyperglycaemia and alpha-glucosidase inhibitors. Diabetes Res. Clin. Pract. 40 (suppl): S51-S555.
4. Campbell RK, White JR Jr., Saulie BA (1996). Metformin: a new oral biguanide. Clin. Ther. 18: 360-371.
5. Efrat S, Linde S, Kofod H, Spector D, Delannoy M, Grant S, Hanahan D, Baekkeskov S (1988). Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene Proc. Nat. Acad. Sci. USA. 85: 9037-9041.
6. Harrower AD (1994). Comparison of efficacy, secondary failure rate, and complications of sulfonylureas. J. Diabetes Complications 8: 201-203.
7. Nair GM, Narasimhan S, Shiburaj S, Abraham TK (2005). Antibacterial effects of Coscinium fenestratum. Fitoterapia 76: 585-587.
8. Pan GY, Huang ZJ, Wang GJ, Fawcett JP, Liu XD, Zhao XC, Sun JG, Xie YY (2003a). The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption. Planta Med. 69:632-636.
9. Pan GY, Wang GJ, Sun JG, Huang ZJ, Zhao XC, Gu Y, Liu XD (2003b). Inhibitory action of berberine on glucose absorption. Yao Xue Xue Bao. 38:911-914.
10. Pinho PMM Paulo, Pinto MMM Madalena, Kijjoa A, Pharadai K, Diaz JG, Herz W (1992). Protoberberine alkaloids from Coscinium fenestratum. Phytochem. 31:1403-1407.
11. Punitha IS, Rajendran K, Shirwaikar A, Shirwaikar A (2005). Alcoholic stem extract of Coscinium fenestratum regulates carbohydrate metabolism and improves antioxidant status in streptozotocin-nicotinamide induced diabetic rats. Evid. Based Complement. Alternat. Med. 2(3): 375-381.
12. Reuser AJ, Wisselaar HA (1994). An evaluation of the potential side-effects of alpha-glucosidase inhibitors used for the management of diabetes mellitus. Eur. J. Clin. Invest. 24 (suppl):19-24.
13. Shirwaikar A, Rajendran K, Punitha IS (2005). Antidiabetic activity of alcoholic stem extract of Coscinium fenestratum in streptozotocin- nicotinamide induced type 2 diabetic rats. J. Ethnopharmacol. 97: 369-374.
14. Singh GB, Singh S, Bani S, Malhotra S (1990). Hypotensive action of a Coscinium fenestratum stem extract. J. Ethnopharmacol. 30: 151-155.
15. Strojek K (2003). Features of macrovascular complications in type 2 diabetic patients. Acta Diabetol. 40 (Suppl 2): S334-S337
16. Varier PS (1994). Indian Medicinal Plants Compendium of 500 Species vol. 2, Orient Longmann Ltd., Hyderabad pp. 191-193.
17. Venukumar MR, Latha MS (2004). Effect of Coscinium fenestratum on hepatotoxicity in rats. Indian J. Exp. Biol .42: 792-797.
18. Yibchok-anun S, Cheng H, Heine PA, Hsu WH (1999). Characterization of receptors mediating AVP- and OT-induced glucagon release from the rat pancreas. Am. J. Physiol. Endocrinol. Metab. 277: E52-E62.
19. Zhou L, Wang X, Shao L, Yang Y, Shang W, Yuan G, Jiang B, Li F, Tang J, Jing H, Chen M (2008). Berberine acutely inhibits insulin secretion from β-cells through 3′,5′-cyclic adenosine 5′-monophosphate signaling pathway. Endocrinol. 149: 4510-4518.